Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis.

Anti-cancer Drugs
Yubao SongZefeng Gao

Abstract

Long noncoding RNA (LncRNA) zinc finger protein multitype 2 antisense RNA 1 (ZFPM2-AS1) is highly expressed in a variety of tumors and is involved in promoting the malignant biological behaviors of cancer cells. However, the mechanism of ZFPM2-AS1 in the progression of hepatocellular carcinoma (HCC) remains to be explored. The ZFPM2-AS1 expression in HCC was measured by quantitative real-time PCR (qRT-PCR); cell counting kit-8, 5-bromo-2'-deoxyuridine (BrdU), and transwell assays were used to confirm the biological functions of ZFPM2-AS1 in regulating the malignant biological behaviors of HCC cells; the luciferase reporter gene assay was employed to detect whether ZFPM2-AS1 could bind to microRNA (miR)-576-3p; the regulatory relationship between ZFPM2-AS1 and miR-576-3p was probed by qRT-PCR; the effects of ZFPM2-AS1 and miR-576-3p on the expression of hypoxia-inducible factor 1α (HIF-1α) were detected by qRT-PCR and Western blot. The expression of ZFPM2-AS1 in HCC tissues, compared with that in normal liver tissues, was significantly upregulated. Knockdown of ZFPM2-AS1 markedly inhibited HCC cell proliferation, migration, and invasion while the overexpression of ZFPM2-AS1 worked oppositely. miR-576-3p could reverse the effects...Continue Reading

References

Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
May 19, 2007·Science·Philipp KapranovThomas R Gingeras
Jun 25, 2010·Cold Spring Harbor Perspectives in Biology·Xiangting WangMichael G Rosenfeld
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jianxin LvHui Xie
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jun 17, 2015·Clinical and Experimental Medicine·Gianluigi MazzoccoliFabio Marra
Aug 25, 2015·Clinical and Experimental Dermatology·S BalciL Tamer
Jan 26, 2016·Journal of Clinical and Translational Hepatology·Sammy SaabRonald W Busuttil
Jan 27, 2016·World Journal of Gastroenterology : WJG·Valery VilchezRoberto Gedaly
May 18, 2016·Biochemical and Biophysical Research Communications·Hao ZhangJianru Xiao
Dec 22, 2016·Biochemical and Biophysical Research Communications·Zheng DongYinying Lu
Jan 22, 2017·Seminars in Diagnostic Pathology·Justin HartkeMarwan Ghabril
Mar 28, 2017·Biochemical and Biophysical Research Communications·Shaya MahatiYongxing Bao
Sep 9, 2017·Cell Proliferation·Jinglin LiXingming Jiang
Oct 23, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jia XiaoXiaogang Wang
May 8, 2018·Pathology, Research and Practice·Khaing Zar ThinJian Cheng Tu
Jul 18, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ji Heon Noh, Myriam Gorospe
Aug 5, 2018·Journal of Cellular Biochemistry·Ying ShenPeng Shang
Sep 13, 2018·Journal of Cellular Biochemistry·Junhao YanZheng Wang
Sep 28, 2018·Molecular Cancer Research : MCR·Evan J GreenawaltChristine M Eischen
May 8, 2019·Cellular & Molecular Biology Letters·Yuree ByunKwanghee Baek
Jul 13, 2019·Journal of Cellular Biochemistry·Min XueXiwen Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.